Suven Life Sciences Ltd

NSE: SUVEN · BSE: 530239 · Healthcare · 34 announcements

Share price: ₹277.90
Market cap: ₹7,852 Cr
Revenue (annual): ₹7.11 Cr
Net profit (annual): ₹-276.3 Cr
P/E (TTM): -20.6×Sector 54.5×
Promoter holding: 65.47%-4.61% QoQ
FII holding: 0.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Preferential Issue 1 Other Announcement 1 Financial Results 1 Business Update 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 Oct 2026 15:55 IST BSE

Board Meeting Date

Suven Life Sciences Board Meeting Date

Suven Life Sciences scheduled its board meeting for 5 November 2026 to approve Q1 and H1 FY27 unaudited results. The trading window closed from 1 October 2026 until 48 hours post-declaration.

Open announcement → Read the filing ↗